Chronic obstructive pulmonary disease • 8: Non-pharmacological management of COPD

Thorax

Volumn 58, Issue 5, 2003, Pages 453-457

  Morgan, M D L ^a   Britton, J R ^b  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NORTRIPTYLINE;

BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; DISABILITY; DISEASE ASSOCIATION; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL ASSESSMENT; NICOTINE REPLACEMENT THERAPY; NURSING; PRIORITY JOURNAL; REDUCTION; REHABILITATION; REVIEW; SEIZURE; SMOKING CESSATION; TASK PERFORMANCE; TRAINING;

BEHAVIOR THERAPY; DISABLED PERSONS; EXERCISE THERAPY; HUMANS; PATIENT EDUCATION; PATIENT PARTICIPATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; SELF CARE; SMOKING CESSATION;

EID: 0038705150     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.5.453     Document Type: Review

References (52)

1. British Thoracic Society. The burden of lung disease. London: British Thoracic Society, 2002.
2. 1 by age and smoking status: facts, figures, and fallacies. Thorax 1997;52:820-7.
3. 1. The Lung Health Study. JAMA 1994;272:1497-505.
4. Anderson JE, Jorenby DE, Scott WJ, et al. Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest 2002;121:932-41.
5. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000;55:987-99.
6. Raw M, McNeill A, West R. Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority. Thorax 1998;53(Suppl 5 Pt 1):S1-19.
7. Silagy C, Mant D, Fowler G, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2000;3:CD000146.
8. Hajek P, West R, Foulds J, et al. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med 1999;159:2033-8.
9. Bohadana A, Nilsson F, Rasmussen T, et al. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2000;160:3128-34.
10. Tashkin D, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001;357:1571-5.
11. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999;340:685-91.
12. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997;337:1195-202.
13. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2001.
14. Parrott S, Godfrey C, Raw M, et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. Thorax 1998;53(Suppl 5 Pt 2):S1-38.
15. Debigare R, Cote CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 2001;164:1712-7.
16. Morgan MD, Singh S, Calverley PM, et al. British Thoracic Society statement on pulmonary rehabilitation. Thorax 2001;56:827-34.
17. American College of Chest Physicians/American Association of Cardiovascular and Pulmonary Rehabilitation (ACCP/AACVPR). Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based guidelines. Chest 1997;112:1363-96.
18. American Thoracic Society. Pulmonary rehabilitation - 1999. Am J Respir Crit Care Med 1999;159:1666-82.
19. Singh SJ, Morgan MD, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019-24.
20. Revill SM, Morgan MD, Singh SJ, et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-22.
21. Butland RJ, Pang J, Gross ER, et al. Two-, six-, and 12-minute walking tests in respiratory disease. BMJ (Clin Res Ed) 1982;284:1607-8.
22. Engstrorn CP, Persson LO, Larsson S, et al. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J 2001;18:69-76.
23. Singh SJ, Sodergren SC, Hyland ME, et al. A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD. Respir Med 2001;95:71-7.
24. Toshima MT, Kaplan RM, Ries AL. Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status. Health Psychol 1990;9:237-52.
25. Vallet G, Ahmaidi S, Serres I, et al. Comparison of two training programmes in chronic airway limitation patients: standardized versus individualized protocols. Eur Respir J 1997;10:114-22.
26. Puente-Maestu L, Sanz ML, Sanz P, et al. Comparison of effects of supervised versus self-monitored training programmes in patients with chronic obstructive pulmonary disease. Eur Respir J 2000;15:517-25.
27. Green RH, Singh SJ, Williams J, et al. A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2001;56:143-5.
28. Simpson K, Killian K, McCartney N, et al. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992;47:70-5.
29. Clark CJ, Cochrane L, Mackay E. Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. Eur Respir J 1996;9:2590-6.
30. Bernard S, Whittom F, LeBlanc P, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:896-901.
31. Clark CJ, Cochrane LM, Mackay E, et al. Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training. Eur Respir J 2000;15:92-7.
32. Lorson JL, Covey MK, Wirtz SE, et al. Cycle ergometer and inspiratory muscle training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:500-7.
33. Revill SM, Singh SJ, Morgan MD Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD. Respir Med 2000;94:778-83.
34. Polkey MI, Hawkins P, Kyroussis D, et al. Inspiratory pressure support prolongs exercise induced lactataemia in severe COPD. Thorax 2000;55:547-9.
35. Honeyman P, Barr P, Stubbing DG. Effect of a walking aid on disability, oxygenation, and breathlessness in patients with chronic airflow limitation. J Cardiopulm Rehabil 1996;16:63-7.
36. Woodcock AA, Johnson M, Geddes D. Cycling in patients with chronic airflow limitation. BMJ (Clin Res Ed) 1983;286:1184.
37. Garrod R, Paul EA, Wedzicha JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax 2000;55:539-43.
38. Ferreira IM, Brooks D, Lacasse Y, et al. Nutritional support for individuals with COPD: a meta-analysis. Chest 2000;117:672-8.
39. Wiroth JB, Bermon S, Andrei S, et al. Effects of oral creatine supplementation on maximal pedalling performance in older adults. Eur J Appl Physiol 2001;84:533-9.
40. Casaburi R. Rationale for anabolic therapy to facilitate rehabilitation in chronic obstructive pulmonary disease. Bailliere's Clin Endocrinol Metab 1998;12:407-18.
41. Steiner MC, Morgan MDL. Enhancing physical performance in COPD. Thorax 2001;56:73-7.
42. Cahalin LP, Braga M, Matsuo Y, et al. Efficacy of diaphragmatic breathing in persons with chronic obstructive pulmonary disease: a review of the literature. J Cardiopulm Rehabil 2002;22:7-21.
43. Gosselink RA, Wagenaar RC, Rijswijk H, et al. Diaphragmatic breathing reduces efficiency of breathing in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:1136-42.
44. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504.
45. Calverley PMA, Bellamy D. The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor relation of airways obstruction? Thorax 2000;55:78-82.
46. Oren A, Sue DY, Hansen JE, et al. The role of exercise testing in impairment evaluation. Am Rev Respir Dis 1987;135:230-5.
47. Yohannes AM, Roomi J, Connolly MJ. Elderly people at home disabled by chronic obstructive pulmonary disease. Age Ageing 1998;27:523-5.
48. Skwarska E, Cohen G, Skwarski KM, et al. Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax 2000;55:907-12.
49. Barber CM, Bradshaw LM, Buttery P, et al. Assisted discharge for patients with exacerbations of COPD. Thorax 2001;56:417-8.
50. Smith B, Appleton S, Adams R, et al. Home care by outreach nursing for chronic obstructive pulmonary disease (Cochrane Review). Cochrane Database Syst Rev 2001;3:CD000994.
51. Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med 1999;160:2000-5.
52. Gallefoss F, Bakke PS, Rsgaard PK. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:812-7.